As per the report, the size of the Global Neurological Monitoring Devices Market was worth USD 8.49 billion in 2019 and estimated to be growing at a CAGR of 7.1%, to reach USD 11.96 billion by 2024.
Standardization is the process for brain monitoring and a growing number of clinical trials for neuro-cognitive diseases are anticipated to offer good opportunities for the market. Brain monitoring devices are being incorporated extensively in hospitals and clinics for assessing the activity of sedatives and anesthesia. Due to the advent of wearable medical devices, the greatest shifting trend is observed in the commercialization and commoditization of Electroencephalography EEG devices. Factors such as the rising incidence and prevalence of neurological disorders, increasing awareness about neurodegenerative diseases, technological developments in devices and increasing incidence of traumatic brain injuries are driving market growth.
On the other hand lack of skilled professionals, high cost of complex devices, poor reimbursement policies and concern regarding the accuracy of diagnostic devices are restricting the Neurological Monitoring Devices Market growth.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 - 2024 |
|
Segments Covered |
By Type, Procedure, Therapeutic Application, End-User, Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
CAS Medical Systems Inc., Compumedics Ltd., Natus Medical Inc., Philips Healthcare, GE Healthcare, AMD Telemedicine, Intel Corporation, Johnson & Johnson, InTouch Health, InTechnology, MEG International Services Ltd., Rimed Inc., Siemens Healthcare, Medtronic Inc., Electrical Geodesics Incorporated, Nihon Kohden Corporation and Advanced Brain Monitoring |
This research report on the Global Neurological Monitoring Devices Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024.
Neurological Monitoring Devices Market – By Type
On the basis of type, Monitors of intracranial pressure & blood flow dynamics segment is leading with the highest shares of the market. Increasing concern towards health and growing demand for effective diagnosis and treatment procedures is boosting up the growth of the market.
Neurological Monitoring Devices Market – By Procedure
On the basis of procedure, Non-invasive procedure is having the highest growth rate form the past decade and is also projected to have a steady pace during the review period. Increasing minimally non-invasive surgical procedures across the world with the growing prevalence of less painful procedure comparatively is outshining the demand of the neurological monitoring devices market.
Neurological Monitoring Devices Market – By Therapeutic Application
On the basis of therapeutic application, Traumatic brain injuries application is holding dominant shares of the market. Rising incidences of road accidents and a number of patients with brain injuries is accelerating the growth of the market.
Neurological Monitoring Devices Market – By End User
On the basis of End-User, the Hospitals sector is leading with largest shares of the market. Growing constructional activities of hospitals with the increasing support from the government is escalating the demand of the market. The rise in the concern towards quality treatment is leveraging the growth of the market.
Regional Analysis:
North America is witnessed in holding the highest shares of the market by owing to increasing revenue in most of the countries. Also, the adoption of the latest technologies and the launch of innovative devices in favor of the end-user is prompting the demand of the market in this region. Europe is positioned next to North America in leading dominant shares of the market. Rising funds from public and private organizations in the medical sector are boosting up the growth of the market. In addition, increasing demand for the treatment of several diseases such as nerve repair and regeneration is magnifying the growth of the market in this region. Asia Pacific is growing tremendously form the past decade and is also to hit the highest CAGR in foreseen years. Rising incidences of several neurodegenerative disorders are leveraging the growth rate of the market. The Middle East and Africa are deemed to have slight variations in the growth graph in the near future.
Some of the major companies operating in the Global Neurological Monitoring Devices Market profiled in this report are:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Monitors of Intracranial Pressure & Blood Flow Dynamics
5.1.2.1 Intracranial Pressure Monitor
5.1.2.2 Jugular Venous Oximetry
5.1.2.3 Transcranial Doppler (TCD) Ultrasonography
5.1.2.4 Near-Infrared Spectroscopy
5.1.2.5 Brain Tissue Oxygen Tension Monitor
5.1.3 Monitors of Brain Electrical Activity
5.1.3.1 Electroencephalography
5.1.3.2 Evoked Potentials
5.1.4 Y-o-Y Growth Analysis, By Type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
5.2 Procedure
5.2.1 Introduction
5.2.2 Non-Invasive
5.2.3 Invasive
5.2.4 Y-o-Y Growth Analysis, By Procedure
5.2.5 Market Attractiveness Analysis, By Procedure
5.2.6 Market Share Analysis, By Procedure
5.3 Therapeutic Application
5.3.1 Introduction
5.3.2 Traumatic Brain Injuries
5.3.3 Stroke
5.3.4 Dementia
5.3.5 Headache Disorders
5.3.6 Sleep Disorders
5.3.7 Epilepsy
5.3.8 Parkinson’s Disease
5.3.9 Huntington’s Disease
5.3.10 Y-o-Y Growth Analysis, By Therapeutic Application
5.3.11 Market Attractiveness Analysis, By Therapeutic Application
5.3.12 Market Share Analysis, By Therapeutic Application
5.4 End User
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Neurological Centers and Institutions
5.4.4 Clinics & Ambulatory Surgical Centers
5.4.5 Diagnostic Centers
5.4.6 Ambulances
5.4.7 Y-o-Y Growth Analysis, By End User
5.4.8 Market Attractiveness Analysis, By End User
5.4.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Procedure
6.1.3.4 By Therapeutic Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Procedure
6.1.4.4 By Therapeutic Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Procedure
6.1.5.4 By Therapeutic Application
6.1.5.5 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 CAS Medical Systems Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Compumedics Ltd.
8.3 Natus Medical Inc.
8.4 Philips Healthcare
8.5 GE Healthcare
8.6 AMD Global Telemedicine
8.8 Intel Corporation
8.9 Johnson & Johnson
8.10 InTouch Health
8.11 InTechnology
8.12 MEG International Services Ltd.
8.13 Advanced Brain Monitoring
8.14 Rimed Inc.
8.15 Siemens Healthcare
8.16 Medtronic Inc.
8.17 Electrical Geodesics Incorporated
8.18 Nihon Kohden Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
